Skip to main content

ABSCINT is a molecular imaging company. ABSCINT has two lead programs in clinical stage, one in cardiovascular disease and one in oncology. The focus of ABSCINT is on single domain antibodies for diagnostics. The technology is used for detection of disease, patient stratification and treatment guidance and evaluation.

Secure your place for BioWin Day: empowering health, the premier event for professionals and decision-makers in the life sciences industry.

Register here!